PT-141 10mg

Original price was: CAD$70.00.Current price is: CAD$60.00.

PT-141, also known as Bremelanotide, is a synthetic peptide that has been studied for its potential effects on sexual dysfunction and arousal. It is derived from the hormone alpha-melanocyte-stimulating hormone (α-MSH), which plays a role in regulating sexual behavior and arousal. According to research, it strengthens the immune system and encourages sexual excitement.

Buy 3 and get 3% off – Buy 5 and get 5% off – Buy 10 and get 10% off

87 in stock

**This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This classification permits the only use of research chemicals for in vitro testing and laboratory research. This website only provides product information for educational purposes. It is illegal to introduce any form of bodily material into either people or animals. Only professionals with the appropriate training and licences should handle this product. This product may not be misbranded, used improperly, or labelled as a medication, food, or cosmetic because it is not one of those things.

Description:

PT-141 has been primarily studied for its potential effects on sexual dysfunction and arousal. It works by activating melanocortin receptors in the brain, specifically targeting the melanocortin receptor 4 (MC4R) and melanocortin receptor 3 (MC3R). Activation of these receptors can lead to increased sexual excitement, improved sexual desire, and arousal in both men and women. This mechanism of action makes PT-141 distinct from other medications used to treat sexual dysfunction, such as phosphodiesterase inhibitors like Viagra, which primarily target blood flow.

PT-141 Research:

Research on PT-141, also known as Bremelanotide, has primarily focused on its effects on sexual dysfunction and arousal in both men and women. Here are some key findings from clinical studies:

Erectile Dysfunction (Men):

  • Studies have shown that PT-141 can induce penile erection in men with erectile dysfunction. It works by increasing blood flow to the genital area, leading to improved erectile function.
  • In a phase 2b clinical trial involving men with mild to moderate erectile dysfunction, PT-141 was found to be more effective than a placebo in improving erectile function.
  • Another study demonstrated that PT-141 produced significant improvements in erectile function, sexual satisfaction, and sexual desire in men with erectile dysfunction who were non-responsive to phosphodiesterase-5 inhibitors (such as Viagra).

Sexual Dysfunction (Female):

  • Clinical trials have shown that PT-141 can increase sexual desire and improve sexual satisfaction in women with hypoactive sexual desire disorder (HSDD) or other forms of female sexual dysfunction.
  • In a phase 3 clinical trial involving premenopausal women with HSDD, PT-141 demonstrated significant improvements in sexual desire and related distress compared to a placebo.
  • Other studies have also reported positive effects of PT-141 on sexual desire, arousal, and satisfaction in women

In a clinical trial published in The Journal of Sexual Medicine in 2013 (Palatin Technologies, Inc.), researchers investigated the use of PT-141 in premenopausal women with female sexual dysfunction. The study found that PT-141, when self-administered as a subcutaneous injection, was associated with increased sexual desire and improved sexual function compared to a placebo. The treatment was generally well tolerated, with the most common side effects being mild-to-moderate nausea and flushing.

 

Certificate of Analysis (COA) and High Performance Liquid Chromatography (HPLC)

Certificate of Analysis | Pt-141 CanadaHigh Performance Liquid Chromatography | Pt-141 Canada

PT-141 10mg
This website uses cookies to improve your experience. By using this website you agree to our Data Protection Policy.
Read more
[]